This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherji, E
Right arrow Articles by Mathes, L E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherji, E
Right arrow Articles by Mathes, L E

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1994 July; 38(7): 1573-1579

Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.

E Mukherji, J L Au and L E Mathes

College of Pharmacy, Department of Veterinary Pathobiology, Ohio State University, Columbus 43210.

ABSTRACT

Dideoxynucleosides such as 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxyinosine (ddI) can effectively inhibit the replication of human immunodeficiency virus (HIV) in T lymphoid cells. There is evidence that HIV can infect and replicate in other cells including monocytoid cells and macrophages. The present study compared the antiretroviral activities of ddI and AZT in three lineages of human cells, i.e., MOLT4 (T lymphocytoid, CD4+), U937 (monocytoid, CD4+), and HT1080 (fibroblastoid, CD4-) cells. Feline leukemia virus, a retrovirus that causes immunodeficiency in cats, was used to infect the cells. The drug concentrations needed to reduce the viral p27 antigen titers in cell lysates by 50% (IC50s) were determined. The data show that AZT and ddI inhibited viral replication in all three cell lines. The IC50s of AZT were 0.02, 1.75, and 2.31 microM in MOLT4, HT1080, and U937 cells, respectively. For ddI, the IC50s were 4.31, 9.52, and 43.5 microM, respectively. These data indicate differential antiviral activities of ddI and AZT in the different cells with the following rank order of drug sensitivity: MOLT4 > HT1080 > U937. A study of the intracellular metabolism of [3H]AZT and [3H]ddI shows that the antiretroviral activities of AZT and ddI in the three cell lines correlated with the levels of their intracellular triphosphate metabolites.


Antimicrob Agents Chemother. 1994 July; 38(7): 1573-1579




This article has been cited by other articles:

  • Cassol, E., Alfano, M., Biswas, P., Poli, G. (2006). Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J. Leukoc. Biol. 80: 1018-1030 [Abstract] [Full Text]  
  • Crawford, M. J., Swenson, C. L., Arnoczky, S. P., O'Shea, J., Ross, H. (2004). Lyophilization Does Not Inactivate Infectious Retrovirus in Systemically Infected Bone and Tendon Allografts. Am J Sports Med 32: 580-586 [Abstract] [Full Text]  
  • Le Saint, C., Terreux, R., Duval, D., Durant, J., Ettesse, H., Dellamonica, P., Guedj, R., Vincent, J. P., Cupo, A. (2004). Determination of ddATP Levels in Human Immunodeficiency Virus-Infected Patients Treated with Dideoxyinosine. Antimicrob. Agents Chemother. 48: 589-595 [Abstract] [Full Text]  
  • Swenson, C. L., Arnoczky, S. P. (2003). Demineralization for Inactivation of Infectious Retrovirus in Systemically Infected Cortical Bone: In Vitro and in Vivo Experimental Studies. JBJS 85: 323-332 [Abstract] [Full Text]  
  • Francke, S., Orosz, C. G., Hayes, K. A., Mathes, L. E. (2000). Effect of Zidovudine on the Primary Cytolytic T-Lymphocyte Response and T-Cell Effector Function. Antimicrob. Agents Chemother. 44: 1900-1905 [Abstract] [Full Text]